Canntab Therapeutics Ltd Price Chart
Canntab Therapeutics Ltd TBF1.BE Financial and Trading Overview
| Canntab Therapeutics Ltd stock price | 0.0040 EUR |
| Previous Close | 0.01 EUR |
| Open | 0.01 EUR |
| Bid | 0.0025 EUR x 0 |
| Ask | 0.02 EUR x 0 |
| Day's Range | 0.01 - 0.01 EUR |
| 52 Week Range | 0.0025 - 0.22 EUR |
| Volume | 6.4K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TBF1.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Canntab Therapeutics Ltd Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.22 EUR |
| 52 Week Low | 0.0025 EUR |
| 50-Day Moving Average | 0.01 EUR |
| 200-Day Moving Average | 0.04 EUR |
TBF1.BE Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Canntab Therapeutics Ltd Stock
What is a current TBF1.BE stock price?
Canntab Therapeutics Ltd TBF1.BE stock price today per share is 0.0040 EUR.
How to purchase Canntab Therapeutics Ltd stock?
You can buy TBF1.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Canntab Therapeutics Ltd?
The stock symbol or ticker of Canntab Therapeutics Ltd is TBF1.BE.
How many shares does Canntab Therapeutics Ltd have in circulation?
The max supply of Canntab Therapeutics Ltd shares is 0.
What is Canntab Therapeutics Ltd Price to Earnings Ratio (PE Ratio)?
Canntab Therapeutics Ltd PE Ratio is now.
What was Canntab Therapeutics Ltd earnings per share over the trailing 12 months (TTM)?
Canntab Therapeutics Ltd EPS is 0 EUR over the trailing 12 months.